UMVA has learned that a pioneering investor is on a mission to revolutionize the way we approach health and longevity, driven by a bold goal: helping one billion people live to 100.
This visionary, Sergey Young, has dedicated his career to challenging the status quo in healthcare investing. Unlike many investors who focus on specific sectors, Sergey's approach is centered around a singular question: how can we help people stay healthier for longer?
The answer to this question led Sergey to create the Longevity Vision Fund, a pioneering investment vehicle that focuses on prevention and regenerative medicine powered by artificial intelligence. By backing cutting-edge research and technologies, Sergey's fund aims to redefine how aging is understood and managed.
For too long, healthcare has been a reactive field, focusing on treating diseases after they appear. But Sergey's work is part of a growing movement that's shifting the paradigm. Researchers are now looking at the biological processes behind aging as a shared root cause of many diseases, rather than treating each condition separately.
This subtle yet profound shift in approach has significant implications for investors. By targeting the underlying biology of aging, investors can support platforms that have the potential to affect multiple conditions at once, from cardiovascular disease to neurodegeneration and metabolic disorders.
Sergey's expertise in evaluating hundreds of biotech opportunities every year has earned him a reputation as a leading voice in the field. He has become a bridge between scientific innovation and investment capital, connecting researchers, founders, and healthcare innovators with the resources they need to bring breakthroughs to life.
His work has not gone unnoticed. Sergey serves on the board of the American Federation for Aging Research, a respected nonprofit organization dedicated to supporting scientific studies on aging and age-related diseases.
One of Sergey's most notable initiatives is the Healthspan XPRIZE, a large-scale competition designed to encourage scientific breakthroughs that can improve human health as people age. This ambitious project reflects Sergey's philosophy: that ambitious goals inspire ambitious solutions.
Sergey's influence extends beyond the investment community. His book, The Science and Technology of Growing Young, has become a Wall Street Journal bestseller, making longevity science accessible to a wider audience.
By translating complex scientific concepts into actionable ideas, Sergey has become a communicator and a thought leader in the field. His work has helped frame longevity as a legitimate area of innovation, attracting serious capital and research attention.
Sergey's mission goes beyond investing; it's a social and economic imperative. He believes that extending healthspan – the period of life spent in good health – could be one of the defining opportunities of this century.
As the field of longevity continues to evolve, Sergey's work demonstrates the power of collaboration between investors, researchers, entrepreneurs, and policymakers. By working together, we can unlock new possibilities for healthier, longer lives – and create a brighter future for humanity.
